Oruka Therapeutics, Inc. Area of Real Estate Property
Oruka Therapeutics, Inc. (ORKA) had Area of Real Estate Property of 5.20 thousand sqft as of 2020-08-29, per its 10-Q filed 2024-08-01.
Discontinued › Notes
us-gaap:AreaOfRealEstateProperty · last filed 2024-08-01
- 2020-08-29: Area of Real Estate Property 5.20K sqft.
- 2013-08-01: Area of Real Estate Property 5.30K sqft.
- 2011-06-30: Area of Real Estate Property 4.50K sqft.
- 2011-06-14: Area of Real Estate Property 4.50K sqft.
| Period end | Area of Real Estate Property |
|---|---|
| 2020-08-29 | 5.20K sqft 10-Q · filed 2024-08-01 |
| 2013-08-01 | 5.30K sqft 10-Q · filed 2021-11-02 |
| 2011-06-30 | 4.50K sqft 10-Q · filed 2013-11-13 |
| 2011-06-14 | 4.50K sqft 10-Q · filed 2013-05-13 |
| 2008-02-08 | 15.00K sqft 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |